Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension

NCT04055415 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

BIOLOGICAL: adipose derived mesenchymal stem cells
DRUG: Conventional drug therapy（expectorant，bronchodilator）

Sponsor

Liaocheng People's Hospital